MCQ – 92328

A 33-year-old female patient presents with symptoms of polycystic ovary syndrome (PCOS) accompanied by hirsutism. Which of the following management strategies is inappropriate for this patient?

Correct Answer » A Explanation

Polycystic Ovary Syndrome (PCOS) management often involves a combination of therapies to target multiple aspects of the condition, such as insulin resistance, androgen excess (which contributes to hirsutism), and menstrual irregularities. Oral contraceptive pills (OCPs) are frequently used to regulate menstrual cycles and reduce androgen levels. However, when a patient has hirsutism, management typically requires more than OCPs alone, as monotherapy with OCPs may not be sufficient to address all symptoms, particularly hirsutism and insulin resistance.

1. OCP + Metformin: This is an appropriate treatment option. OCPs help regulate menstrual cycles and lower androgen levels, while metformin addresses insulin resistance, a key factor in PCOS.
2. OCP + Antiandrogens: This is a valid strategy for managing hirsutism in PCOS. Antiandrogens (such as spironolactone or finasteride) block the effects of excess androgens, which contribute to hirsutism.
3. OCP (Oral Contraceptive Pills) alone: This is inappropriate for managing PCOS with hirsutism because OCPs alone may not effectively reduce hirsutism or insulin resistance. The management of PCOS-related hirsutism typically requires additional treatment with antiandrogens or insulin-sensitizing agents like metformin.
4. OCP + Lifestyle modifications: This is an effective approach. Lifestyle changes such as weight loss, diet, and exercise are crucial for improving insulin sensitivity and overall metabolic health in PCOS, which can help reduce hirsutism and improve other symptoms.